Search

Search Results
Results 18701 - 18710 of 19579 for stroke
  • Fragmin
    Drug - 16 Dec 2025
    Consumer Medicine Information (CMI) about Fragmin intended for persons living in Australia.
  • DBL Bleomycin
    Drug - 15 Dec 2025
    Consumer Medicine Information (CMI) about DBL Bleomycin intended for persons living in Australia.
  • Levemir Penfill
    Drug - 15 Dec 2025
    Consumer Medicine Information (CMI) about Levemir Penfill intended for persons living in Australia.
  • Actrapid, Protaphane, Mixtard 30/70
    Drug - 15 Dec 2025
    Consumer Medicine Information (CMI) about Actrapid, Protaphane, Mixtard 30/70 intended for persons living in Australia.
  • Reagila
    Drug - 15 Dec 2025
    Consumer Medicine Information (CMI) about Reagila intended for persons living in Australia.
  • Levemir FlexPen
    Drug - 12 Dec 2025
    Consumer Medicine Information (CMI) about Levemir FlexPen intended for persons living in Australia.
  • Perisyl Combi
    Drug - 9 Dec 2025
    Consumer Medicine Information (CMI) about Perisyl Combi intended for persons living in Australia.
  • Ryzodeg 70/30 Penfill
    Drug - 4 Dec 2025
    Consumer Medicine Information (CMI) about Ryzodeg 70/30 Penfill intended for persons living in Australia.
  • They need a ventilator to stay alive. Getting one can be a nightmare.
    News - 2 Dec 2025
    On vacation in Mexico last year, Michael DiPlacido passed out twice while scuba diving and again in his hotel. Back in St. Louis, doctors diagnosed him with amyotrophic lateral sclerosis, or ALS, an...
  • Actrapid Vial, Protaphane Vial
    Drug - 1 Dec 2025
    Consumer Medicine Information (CMI) about Actrapid Vial, Protaphane Vial intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback